Aclarion announces initial payer coverage of Nociscan by AXA in London, UK

Aclarion announced their initial payer coverage of Nociscan by AXA in London, UK in conjunction with The London Clinic, one of the UK’s largest and most renowned independent hospitals. AXA is a leading provider of private medical insurance in the UK. “Securing first payer coverage is the most significant milestone Aclarion has achieved to date,” said Brent Ness, CEO Aclarion. “This is a monumental step in launching widescale commercialization efforts at Aclarion. Nothing becomes standard of care in healthcare without reimbursement and we have now validated our strategy in one of the largest, most sophisticated healthcare markets in the world. We anticipate additional coverage decisions in the weeks to come and will be filling reimbursed markets with sales teams trained to drive adoption. We are very committed to serving the needs of the patients covered by this AXA payer decision. Evidence to date demonstrates that when Nociscan is incorporated into the treatment plan, outcomes significantly improve. This evidence and our physician support is why other payers will be following AXA’s example.”